VYEPTI (eptineumab-jjmr)

Vyepti is indicated for the preventive treatment of migraine in adults. Vyepti is a humanized immunoglobulin monoclonal antibody specific for calcitonin gene-related peptide Ligand. Safety and effectiveness in pediatric patients have not been established.